Table 4.
Increase in BCVA (Snellen) and reduction in IOP (mmHg) and AGD (numbers), comparing values pre to post phaco-ELT
| Mean ± SD | Percentage | Confidence Interval | P Value | ||
|---|---|---|---|---|---|
| All eyes |
Δ BCVA (post-pre) |
+0.3 ± 0.3 |
+80.5 % |
0.3 – 0.4 |
p < 0.001 * |
| Δ IOP (post-pre) |
−4.5 ± 5.9 mmHg |
−23.0 % |
3.0 – 6.1 |
p < 0.001 * |
|
| Δ AGD (post-pre) |
−0.9 ± 1.5 |
−38.9 % |
0.5 – 1.3 |
p < 0.001 * |
|
| Study group |
Δ BCVA (post-pre) |
+0.3 ± 0.3 |
+82.5 % |
0.2 – 0.4 |
p < 0.001 * |
| Δ IOP (post-pre) |
−1.9 ± 4.4 mmHg |
−11.5 % |
0.4 – 3.3 |
p = 0.012 * |
|
| Δ AGD (post-pre) |
−1.1 ± 1.4 |
−42.9 % |
0.6 – 1.5 |
p < 0.001 * |
|
| Control group | Δ BCVA (post-pre) |
+0.3 ± 0.3 |
+78.6 % |
0.2 – 0.5 |
p < 0.001 * |
| Δ IOP (post-pre) |
−9.5 ± 5.4 mmHg |
−36.6 % |
6.9 – 12.0 |
p < 0.001 * |
|
| Δ AGD (post-pre) | −0.7 ± 1.6 | −29.5 % | 0.1 – 1.4 | p = 0.085 |
Abbreviations: pre before phaco-ELT, post 12 month after phaco-ELT, SD standard deviation, * statistically significant.